These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 11991859)
1. Biological role of phosphatase PTEN in cancer and tissue injury healing. Tsugawa K; Jones MK; Sugimachi K; Sarfeh IJ; Tarnawski AS Front Biosci; 2002 May; 7():e245-51. PubMed ID: 11991859 [TBL] [Abstract][Full Text] [Related]
2. Abnormal PTEN expression in portal hypertensive gastric mucosa: a key to impaired PI 3-kinase/Akt activation and delayed injury healing? Tsugawa K; Jones MK; Akahoshi T; Moon WS; Maehara Y; Hashizume M; Sarfeh IJ; Tarnawski AS FASEB J; 2003 Dec; 17(15):2316-8. PubMed ID: 14525948 [TBL] [Abstract][Full Text] [Related]
3. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death. Weng LP; Smith WM; Dahia PL; Ziebold U; Gil E; Lees JA; Eng C Cancer Res; 1999 Nov; 59(22):5808-14. PubMed ID: 10582703 [TBL] [Abstract][Full Text] [Related]
4. Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway. Ramaswamy S; Nakamura N; Vazquez F; Batt DB; Perera S; Roberts TM; Sellers WR Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2110-5. PubMed ID: 10051603 [TBL] [Abstract][Full Text] [Related]
5. Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis. Davies MA; Lu Y; Sano T; Fang X; Tang P; LaPushin R; Koul D; Bookstein R; Stokoe D; Yung WK; Mills GB; Steck PA Cancer Res; 1998 Dec; 58(23):5285-90. PubMed ID: 9850049 [TBL] [Abstract][Full Text] [Related]
6. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells. St-Germain ME; Gagnon V; Mathieu I; Parent S; Asselin E Int J Oncol; 2004 May; 24(5):1311-24. PubMed ID: 15067356 [TBL] [Abstract][Full Text] [Related]
7. Role of PTEN and Akt in the regulation of growth and apoptosis in human osteoblastic cells. Nielsen-Preiss SM; Silva SR; Gillette JM J Cell Biochem; 2003 Dec; 90(5):964-75. PubMed ID: 14624456 [TBL] [Abstract][Full Text] [Related]
8. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells. Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of vascular smooth muscle cell proliferation, migration, and survival by the tumor suppressor protein PTEN. Huang J; Kontos CD Arterioscler Thromb Vasc Biol; 2002 May; 22(5):745-51. PubMed ID: 12006385 [TBL] [Abstract][Full Text] [Related]
10. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Sun H; Lesche R; Li DM; Liliental J; Zhang H; Gao J; Gavrilova N; Mueller B; Liu X; Wu H Proc Natl Acad Sci U S A; 1999 May; 96(11):6199-204. PubMed ID: 10339565 [TBL] [Abstract][Full Text] [Related]
12. PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells. Li DM; Sun H Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15406-11. PubMed ID: 9860981 [TBL] [Abstract][Full Text] [Related]
13. PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3-kinase/Akt-dependent and -independent pathways. Weng L; Brown J; Eng C Hum Mol Genet; 2001 Feb; 10(3):237-42. PubMed ID: 11159942 [TBL] [Abstract][Full Text] [Related]
14. Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC. Haas-Kogan D; Shalev N; Wong M; Mills G; Yount G; Stokoe D Curr Biol; 1998 Oct; 8(21):1195-8. PubMed ID: 9799739 [TBL] [Abstract][Full Text] [Related]
15. Regulation of phosphoinositide metabolism, Akt phosphorylation, and glucose transport by PTEN (phosphatase and tensin homolog deleted on chromosome 10) in 3T3-L1 adipocytes. Ono H; Katagiri H; Funaki M; Anai M; Inukai K; Fukushima Y; Sakoda H; Ogihara T; Onishi Y; Fujishiro M; Kikuchi M; Oka Y; Asano T Mol Endocrinol; 2001 Aug; 15(8):1411-22. PubMed ID: 11463863 [TBL] [Abstract][Full Text] [Related]
16. Nuclear PTEN-mediated growth suppression is independent of Akt down-regulation. Liu JL; Sheng X; Hortobagyi ZK; Mao Z; Gallick GE; Yung WK Mol Cell Biol; 2005 Jul; 25(14):6211-24. PubMed ID: 15988030 [TBL] [Abstract][Full Text] [Related]
17. The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells. Asano T; Yao Y; Zhu J; Li D; Abbruzzese JL; Reddy SA Oncogene; 2004 Nov; 23(53):8571-80. PubMed ID: 15467756 [TBL] [Abstract][Full Text] [Related]
18. Regulation of sensitivity to TRAIL by the PTEN tumor suppressor. Whang YE; Yuan XJ; Liu Y; Majumder S; Lewis TD Vitam Horm; 2004; 67():409-26. PubMed ID: 15110188 [TBL] [Abstract][Full Text] [Related]
19. The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells. She QB; Solit DB; Ye Q; O'Reilly KE; Lobo J; Rosen N Cancer Cell; 2005 Oct; 8(4):287-97. PubMed ID: 16226704 [TBL] [Abstract][Full Text] [Related]
20. PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein. Paramio JM; Navarro M; Segrelles C; Gómez-Casero E; Jorcano JL Oncogene; 1999 Dec; 18(52):7462-8. PubMed ID: 10602505 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]